In our study, we found that patients with lymphatic metastasis had higher NAT10 expression levels than those without lymphatic metastasis, and we speculated that NAT10 may promote lymphatic metastasis in HNSCC. The gene discussed is NAT10; the disease is head and neck squamous cell carcinoma.